A program to collect cancer-related samples and data for better cancer care
Official title: INST UNM 1521: Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Run by New Mexico Cancer Research Alliance · NCT03977402 · Data updated 2026-11-12
This study is collecting blood, tissue, and other samples from people with cancer or at risk of it to help improve cancer care and treatment in the future.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 47500 (estimated) |
| Sponsor | New Mexico Cancer Research Alliance Academic / other |
| Locations | 1 site (Albuquerque, New Mexico) |
| Status | Recruiting |
| Started | January 27, 2016 |
| Main results expected | December 31, 2036 |
| Study ends | December 31, 2037 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT03977402 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 18 and older who have been diagnosed with cancer or are suspected of having cancer.
✕Probably not a fit
Patients who are prisoners will not be eligible to participate in this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This program aims to enhance cancer care by creating a comprehensive repository of biological samples and associated data from patients diagnosed with cancer or at risk of developing it. Participants will provide blood, tissue, and other biological samples, along with survey responses and medical records, to support ongoing cancer research and personalized medicine initiatives. The data collected will be utilized to facilitate new clinical trials and improve cancer treatment standards through collaboration with various healthcare providers. This is an observational study, meaning it does not involve any treatment interventions.
Why it matters
Potential benefit: If successful, this initiative could lead to significant advancements in personalized cancer treatment and improved patient outcomes.
How similar studies have gone: Other studies have successfully established similar biorepositories, indicating a promising approach to enhancing cancer research and treatment.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age and older. * Has a diagnosis of cancer or is suspected of having cancer. * Able to understand and sign the Informed Consent form directly. * Pregnant women are permitted to be enrolled. Exclusion Criteria: * Prisoners
Where it's running
-
University of New Mexico Comprehensive Cancer Center
Albuquerque, New Mexico, United States Recruiting
Study contacts
- Principal investigator: Leslie Andritsos, MD — University of New Mexico Cancer Center
- Study coordinator: Ellen Wojcik, MBA-HCM
- Email: ewojcik@salud.unm.edu
- Phone: 505 272-4946
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oncology biobank and longitudinal sample collection at NYCBS
This collects and stores blood, tissue, and health information from adults with cancer, people at higher risk, and healthy donors to help researchers test new cancer tests and treatments.
-
AI (Mirai)-guided supplemental MRI to find breast cancer in women at high Mirai risk
This will test whether adding a screening breast MRI finds more cancers in women whose mammograms are flagged as high risk by the Mirai AI model.
-
Community registry for cancer risk assessment and prevention
This study is collecting information from adults at higher risk for cancer to see how we can improve cancer screening and prevention in the community.
-
Collecting data to predict cancer risk in at-risk populations
This study is trying to collect samples and health information from people at higher risk of cancer to see if they can find signs that help predict cancer early on.
-
A program to improve cancer care for the community
This study is trying to improve cancer care for African American patients by collecting health information and biological samples to help develop better treatments tailored to their needs.
-
Partnership with patients at risk of cancer
This study is collecting blood, tissue, and other samples from cancer patients and those at risk to see how it can help improve cancer care and support future research.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.